Allied Market Research
Loading...
Cart
0
PURCHASE OPTIONS

Start reading ,This title and over 12000 thousand more,available with Avenue Library, T&C*

Allied Market Research

Brugada Syndrome Market by Diagnosis (Electrocardiogram, Electrophysiology Test, Genetic Testing, and Others), Treatment (Implantable Cardioverter-Defibrillator, and Drug Therapy), and End User (Hospitals & Clinics, Surgical Centers, Diagnostic Centers, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2028

A11449
Pages: NA
Aug 2021 | 27 Views
 
Author(s) : Onkar Sumant
Tables: NA
Charts: NA
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Brugada Syndrome Market

Request Now !

Brugada syndrome is a genetic disorder in which the heart's electrical activity becomes abnormal. Therefore, it increases the risk of abnormal rhythm of heart and even sudden cardiac death. Moreover, those affected by this syndrome may have episodes of passing out. The abnormal heart rhythms in patients often occur when they are at rest. However, the abnormality can get triggered by fever. About 25% of those with Brugada syndrome have a family member who is suffering from this condition. However, some cases could be due to certain medications or a new mutation. As no cure has been found for Brugada syndrome, treatments are often focused on using an implantable cardioverter defibrillator (ICD). This condition affects between 1 and 30 per 10,000 people, and is more common among males than females.

Market Scope and Structure Analysis

Report Metric

Details

Market Size Available for Years

  2020–2028

  Base Year Considered

  2020

  Forecast Period

  2021–2028

  Forecast Unit

  Value (USD)

  Segments Covered

  Diagnosis, Treatment, End User, and Region

  Regions Covered

  North America, Europe, Asia-Pacific, LAMEA

  Companies Covered

Novartis AG, F. Hoffmann-La Roche Ltd, Boehringer Ingelheim International GmbH., Pfizer Inc., Ionis Pharmaceuticals, Abbott, Novo Nordisk A/S, Takeda Pharmaceutical Company Limited., AstraZeneca, CYTOKINETICS, INC., Regeneron Pharmaceuticals Inc., Salarius Pharmaceuticals, Inc., Leadiant Biosciences, Inc., PTC Therapeutics., Natera, , Inc., and Catalyst Pharmaceuticals, Inc.

 

COVID-19 Impact Analysis

COVID-19 is an infectious disease that originated in the Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing a shortage of these drugs. Thus, the pharmaceutical and biotechnology industry industries are expected to witness significant growth in the future, owing to the demand for vaccines and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the Brugada syndrome market.

Top Impacting Factors

Alarming rise in prevalence of heart diseases is the key factor driving the growth of the global Brugada syndrome market. In addition, huge demand for treatment and diagnosis methods has positively impacted the market.

Moreover, increase has been witnessed in the availability of diagnostic services for respiratory diseases, which has significantly fueled the growth of the market. Furthermore, rise in awareness regarding such rare syndromes has enabled patients to take appropriate medical treatments, which acts as a key factor contributing toward the growth of the global market.

Furthermore, reimbursement policies offered by government and private insurance organizations in countries such as the UK, Canada, Germany, and the U.S. propels the market growth.

Other factors that contribute to the growth of the market are the influence of western culture among adults, lifestyle changes, and addiction to smoking. In addition, exposure to harmful chemicals and environmental pollution boost the market growth. However, high cost associated with the treatment of Brugada syndrome hinders market growth.

Key Market Trends

Various companies are focusing on organic growth strategies, which include product approvals, product launches, and others such as events and patents. Inorganic growth strategies that are majorly adopted by key players include partnership & collaborations and acquisitions.

These activities have paved way for the expansion of the customer base and business of market players such as GE Healthcare and GeneDx, Inc.

Asia-Pacific is expected to witness the fastest growth attributed to increase in focus on the treatment of heart diseases and a huge demand for diagnostic tests. Alarming rise in environmental pollution in this region is likely to bring up more cases of heart diseases and syndromes.

The African market for Brugada syndrome exhibits a steady growth due to increase in awareness about chronic health conditions and the development of better healthcare facilities. This region has been witnessing a flourishing growth in the diagnostic devices market as well such as computed tomography (CT) and magnetic resonance imaging (MRI). As the awareness about chronic obstructive pulmonary disease (COPD) in Africa is rising, the acceptability of novel therapies is increasing among patients.

Key Segments Covered

Segment

Subsegment

  Diagnosis

  • Electrocardiogram
  • Electrophysiology (EP) Test
  • Genetic Testing
  • Others

  Treatment

  • Implantable Cardioverter-Defibrillator
  • Drug Therapy
    • Antiarrhythmic Drugs
    • Psychotropic Drugs
    • Anesthetics/Analgesics,
    • Others

  End-Users

  • Hospitals and Clinics
  • Surgical Centers
  • Diagnostic Centers
  • Others

  Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

 

Key Benefits of the Report

  • This study presents the analytical depiction of the Brugada syndrome industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the market share.
  • The current market is quantitatively analyzed from 2020 to 2028 to highlight the Brugada syndrome market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed market analysis depending on competitive intensity and how the competition will take shape in the coming years

Questions Answered in the Global Brugada syndrome Market Report

  • Which are the leading players active in the Brugada syndrome market?
  • How is each segment of the market expected to grow during 2021–2028?
  • What are the adoption trends for Brugada syndrome in emerging economies and established economies across the world?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps?
  • What is Brugada syndrome immunotherapy?
  • What is Brugada syndrome market prediction in the future?
  • What are the current trends and predicted trends?
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
 
PURCHASE OPTIONS

Start reading ,This title and over 12000 thousand more,available with Avenue Library, T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

 
Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.

RELATED TAGS

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

REQUEST TOC/SAMPLE

OR

Purchase Full Report of
Brugada Syndrome Market

  • Online Only
  • $3,456  $3,110
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769  $5,192
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450  $5,805
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8,995  $8,096
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading.
    This title and over 12,000+ are available on the Avenue Library. T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers